ARTICLE
Auteur(s) :, Hikaru ISHIGAKI1, Naohito
HATTA1,*, Mizuki YAMADA1, Hidemitsu
ORITO2, Kazuhiko TAKEHARA1
1Department of Dermatology, Kanazawa University
School of Medicine, 13-1 Takaramachi, Kanazawa, 920-8641 Japan
2Division of Dermatology, Suzu City Hospital, Suzu,
927-1213 Japan
accepté le 15 Mars 2004
Langerhans cell histiocytosis (LCH) includes diseases previously
called histiocytosis X, eosinophilic granuloma and Lettere-Siwe
disease. LCH is characterized by a broad spectrum of clinical
presentations which involves one or more body organ systems such as
bone, liver, hypothalamus, skin and mucous membrane [1, 2]. These
diseases are usually observed in children, however, they sometimes
affect elderly patients. Solitary LCH, which is most often seen in
adults, has a benign clinical course, while multi-organ LCH, most
often seen in children, has an acute, aggressive and sometimes
fatal clinical course. We here report an adult case where LCH
presented with vulvar ulcers and discuss the literature of similar
clinical features.
Case report
A 65-year-old Japanese woman first visited our clinic with a
2-month-history of stinging on urination. Physical examination
revealed multiple ulcers, 20-30 mm in diameter, on the vulva and
perineum lesion. These lesions were infiltrated and were surrounded
with red papules (( Figure 1 )). There was
bilateral inguinal lymph node swelling but no hepato-splenomegaly.
Laboratory examination results were almost normal. A skeletal
radiographic survey showed no evidence of bone involvement.
Computed tomography did not show any abnormality suggesting
multi-organ involvement, except for swollen inguinal lymph nodes.
A biopsy taken from the ulcer revealed diffuse proliferation of
large histiocytic cells with bright cytoplasm in the dermis and
subcutaneous lesions, accompanied by scattered eosinophils. The
large histiocytic cells had lobulated and grooved ‘coffee bean’ or
reniform nuclei (( Figure 2 )) and were
positive for S-100 protein, CD1a, CD4 and HLA-DR antigen by
immunohistochemistry using specific antibodies (( Figure 3 )).
Ultrastructurally, the proliferating cells were found to contain
typical Birbeck granules in the cytoplasm (( Figure 4 )). In view
of all of these findings, the patient was diagnosed as having
LCH.
She underwent complete excision of the genital lesion followed
by local skin flap-reconstruction, and bilateral inguinal lymph
node biopsy. No tumor cells were found in the lymph nodes. There
has been no evidence of local or systemic disease during 12 months
of follow up.
Discussion
The cutaneous lesions may be a sole manifestation of LCH, in
addition to multi-organ diseases. The seborrheic dermatitis-like
lesions on the scalp and the flexeres (groin, perianal, axilla,
neck and behind the ear) are typical of the skin involvement of LCH
[2]. Although genital lesions are relatively rare for skin
involvement of LCH, at least 24 adult cases with genital
manifestation have been reported in the English literature [3-12]
(Table I( Table I )). All but
one patient was female and the median age was 38 years. Vulval
ulcers with or without papules or nodules were the most common
clinical feature. Five of the 22 (23%) also presented with other
extragenital skin involvements such as head and ‘flexer’ lesions.
Thus, vulvar ulcers seem to be one of the typical cutaneous
manifestations of adult LCH. We must consider the possibility of
LCH when we encounter a woman with atypical chronic ulcers or
papulo-erythematous lesions on the vulva.
However, the clinical diagnosis of any ulcerative lesion is
difficult and a biopsy is usually needed for correct diagnosis.
Histologically, the lesion contains proliferating Langerhans-type
histiocytes, characterized by eosinophilic cytoplasm and reniform
vesicular nuclei. These cells express S-100 protein and exhibit a
D-mannosidase activity. Definitive diagnosis requires the findings
of Birbeck granules by electron microscopy or positivity for CD1a
by immunohistochemistry in lesional cells. The Writing Group of the
Histiocyte Society has identified three levels of confidence in the
diagnosis of LCH [13]. The present case was diagnosed as
“definitive LCH” by these criteria.
Treatment for genital LCH is not well-defined because there have
been few reports of cases. In general, the treatment strategy is
different for patients with and without systemic involvement. In
the patients with genital LCH, 9 of the 21 (43%) were
complicated with systemic disease. Systemic LCH may be present at
the same time, or develop subsequently. A single systemic disease
can be treated with local therapy including surgical excision,
radiotherapy, topical corticosteroid, and topical nitrogen mustard.
For multisystem LCH, cyclosporin, 2-chlorodeoxyadenisine and
etoposide are used [1, 2]. Complete remissions were reported with
vincristine and vinblastine in genital LCH [8, 9]. We performed
local excision in the present case as there was no systemic sign of
LCH. Although there was no evidence of recurrence in the 1-year
follow-up period, further observation will be needed for both local
recurrence and subsequent multi-organ disease.
Table I Genital Langerhans Cell Histiocytosis
|
No.
|
Age
|
Gender
|
Cutaneous presentation
|
Systemic disease
|
Treatment
|
Outcome
|
Ref.
|
|
Genital
|
Ex-genital
|
|
1
|
NA
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
SX
|
IMP
|
[3]
|
|
2
|
38
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
SX
|
CR
|
[3]
|
|
3
|
42
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
RTX
|
PR
|
[3]
|
|
4
|
29
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
SX, RTX
|
UR
|
[3]
|
|
5
|
33
|
F
|
cervical ulcer
|
(-)
|
(-)
|
SX
|
CR
|
[3]
|
|
6
|
85
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
steroid
|
UR
|
[3]
|
|
7
|
36
|
F
|
vulvar ulcer
|
skin eruption
|
DI, lung,bone
|
RTX, SX, steroid
|
UR
|
[3]
|
|
8
|
36
|
F
|
vulvar induration
|
(-)
|
lung
|
SX
|
CR
|
[3]
|
|
9
|
38
|
F
|
vaginal papules
|
skin lesion
|
DI
|
RTX
|
CR
|
[3]
|
|
10
|
20
|
F
|
vulvar ulcer
|
(-)
|
bone
|
RTX
|
CR
|
[3]
|
|
11
|
35
|
F
|
vulvar nodules
|
(-)
|
DI
|
RTX
|
IMP
|
[3]
|
|
12
|
22
|
F
|
vulvar nodules
|
(-)
|
bone
|
steroid
|
CR
|
[3]
|
|
13
|
27
|
F
|
vaginal discharge
|
(-)
|
bone
|
CTX, steroid
|
PR
|
[3]
|
|
14
|
76
|
F
|
vulvar papules/erosion
|
NA
|
NA
|
NA
|
NA
|
[4]
|
|
15
|
54
|
F
|
vulvar papules
|
NA
|
NA
|
NA
|
NA
|
[4]
|
|
16
|
54
|
M
|
palules on penis
|
NA
|
NA
|
NA
|
NA
|
[4]
|
|
17
|
62
|
F
|
vulvar ulcer
|
(-)
|
bone
|
CTX, RTX, SX
|
CR
|
[5]
|
|
18
|
65
|
F
|
vulvar ulcer
|
axilla
|
(-)
|
RTX
|
CR
|
[6]
|
|
19
|
46
|
F
|
vulvar ulcer
|
axilla, scalp, groin
|
NA
|
NA
|
NA
|
[7]
|
|
20
|
19
|
F
|
vulvar lesion
|
(-)
|
bone
|
CTX
|
CR
|
[8]
|
|
21
|
40
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
CTX, SX
|
CR
|
[9]
|
|
22
|
45
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
RTX
|
CR
|
[10]
|
|
23
|
90
|
F
|
perivulvar lesion
|
perianal, axilla
|
(-)
|
nitrogen mustard
|
CR
|
[11]
|
|
24
|
36
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
RTX
|
CR
|
[12]
|
|
25
|
65
|
F
|
vulvar ulcer
|
(-)
|
(-)
|
SX
|
CR
|
present case
|
References
1 Howarth DM, Gilchrist GS, Mullan BP,
Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans
cell histiocytosis: diagnosis, natural history, management, and
outcome. Cancer 1999; 85: 2278-90.
2 Chu T. Langerhans cell histiocytosis. Australas J
Dermatol 2001; 42: 237-42.
3 Axiotis CA, Merino MJ, Duray PH. Langerhans
cell histiocytosis of the female genital tract. Cancer 1991; 67:
1650-60.
4 Meehan SA, Smoller BR. Cutaneous Langerhans cell
histiocytosis of the genitalia in the elderly: a report of three
cases. J Cutan Pathol 1998; 25: 370-4.
5 Takata M, Taniguchi A, Imai T, Hirone T,
Nonomura A, Fukui Y. An adult case of histiocytosis X
with a vulvar ulcer and multiple bone lesions. J Dermatol 1994; 21:
259-63.
6 Modi D, Schulz EJ. Skin ulceration as sole
manifestation of Langerhans-cell histiocytosis. Clin Exp Dermatol
1991; 16: 212-5.
7 Hoang MP, Owen SA, Haisley-Royster C,
Allen MH, Shea CR, Selim MA. Papular eruption of the
scalp accompanied by axillary and vulvar ulcerations. Arch Dermatol
2001; 137: 1241-6.
8 Stentella P, Cipriano L, Covello R, Faticanti
Scucchi L, Frega A. Langerhans cell histiocytosis of
vulva and cervix in a 19-year-old woman. Gynecol Obstet Invest
1997; 44: 67-9.
9 Solano T, Espana A, Sola J, Lopez G.
Langerhans’ cell histiocytosis on the vulva. Gynecol Oncol 2000;
78: 251-4.
10 Pather S, Moodley JM, Bramdev A. Isolated
Langerhans cell histiocytosis of the vulva: a case report. J Obstet
Gynaecol Res 2001; 27: 111-5.
11 Szepietowski J, Toonstra J, Van der Putte SCJ,
Tegelberg-Stassen MJAM, Van Vloten WA. Langerhans-cell
histiocytosis in a nonagenarian. Report of a case with a literature
review of patients older than 70 years. Eur J Dermatol 1994;
4: 216-20.
12 Voelklein K, Horny HP, Marzusch K,
Dietl J. Primary Langerhans cell histiocytosis of the vulva.
Gynecol Obstet Invest 1993; 36: 189-90.
13 Chu T, D’Angio GJ, Favara B, Ladisch S,
Nesbit M, Pritchard J, The Writing Group of the
Hisitiocyte Society. Histiocytosis syndromes in children. Lancet
1987; 1: 208-9.
|